GGrantIndex
Sort

51,570 grants matching autoimmune disease

Ca2+ and secretory dynamics in salivary acinar cells

$572,940
David I Yule · University Of Rochester · R01 · FY2025 · DE

Centralized Pain Phenotype as a Predictor of Opioid Non-responsiveness

$572,891
Daniel J Clauw · University Of Michigan At Ann Arbor · R01 · FY2020 · DA

Epidemiology of Heterogenity in Type 2 Diabetes

$572,737
Massimo T Pietropaolo · University Of Michigan At Ann Arbor · R01 · FY2008 · DK

Paradigms of maintaining anterior segment homeostasis

$572,687
A. Sue Menko · Thomas Jefferson University · R01 · FY2024 · EY

Neuronal antigen surveillance and autoimmunity in CNS demyelinating disease

$572,672
Charles Lee Howe · Mayo Clinic Rochester · R01 · FY2024 · NS

Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University

$572,582
Robin S Goland · Columbia University Health Sciences · U01 · FY2009 · DK

Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip

$572,535
Alberto Ascherio · Harvard School Of Public Health · R01 · FY2012 · NS

Paradigms of maintaining anterior segment homeostasis

$572,513
A. Sue Menko · Thomas Jefferson University · R01 · FY2025 · EY

Harnessing TNFa Signaling To Improve Therapeutic Response In Pancreatic Cancer

$572,447
Kian H Lim · Washington University · R01 · FY2024 · CA

The Role of Inflammation in Regulating Gastric Metaplasia

$572,370
Richard J Dipaolo · Saint Louis University · R01 · FY2023 · DK

Prospective Study of 'PANDAS'

$572,214
University Of Florida · R01 · FY2005 · MH

Structure-based Design of Rational PF4 Inhibitors in HIT

$572,191
Douglas Brock Cines · University Of Pennsylvania · R01 · FY2020 · HL

Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer

$572,168
Dan R Littman · New York University School Of Medicine · R01 · FY2025 · CA

Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer

$572,168
Dan R Littman · New York University School Of Medicine · R01 · FY2021 · CA

Project 2: Metabolic and Immune Systems of Biology Interactions as Initiators and Drivers of Alzheimer's Pathology in Brain: Therapeutic Targets and Windows

$572,124
Roberta Diaz Brinton · University Of Arizona · P01 · FY2023 · AG

Gender, sex steroids and dry eye syndromes

$572,080
Schepens Eye Research Institute · R01 · FY2003 · EY

Immunoregulatory Defects In Inflammatory Bowel Disease

$571,939
Warren Strober · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

VitGene International Consortium to Identify Susceptibility Genes for Generalized

$571,906
Richard A Spritz · University Of Colorado Denver · R01 · FY2011 · AR

Characterization of SLE-susceptibility loci on mouse chromosome 1

$571,817
Laurence Morel · University Of Florida · R01 · FY2021 · AI

Targeting glutamate carboxypeptidase in perinatal brain injury

$571,782
Sujatha Kannan · Johns Hopkins University · R01 · FY2023 · NS

Air Pollution and Pregnancy Loss

$571,768
Marianthi-Anna Kioumourtzoglou · Columbia University Health Sciences · R01 · FY2020 · ES

DAP12 and the host response to cryptococcosis

$571,755
Lena J Heung · Cedars-Sinai Medical Center · R01 · FY2022 · AI

The role of cytotoxic T cells in rheumatoid arthritis pathogenesis

$571,495
Felipe Andrade · Johns Hopkins University · R01 · FY2024 · AR

IRF5 and Macrophage Activation Syndrome in systemic Juvenile Idiopathic Arthritis

$571,447
Jessica A Hamerman · Benaroya Research Inst At Virginia Mason · R01 · FY2021 · AR

Mechanisms of mucosal autoinflammation elucidated by a novel monogenic transcription factor defect

$571,333
Carrie L. Lucas · Yale University · R01 · FY2021 · AI